Biological drugs in patients with psoriasis: a drug-utilization study using Tuscan administrative data banks

Study identification

• EU PAS number:
  EUPAS45365
• Study ID:
  45366
• Official title and acronym:
  Biological drugs in patients with psoriasis: a drug-utilization study using Tuscan administrative data banks
• DARWIN EU® study:
  No
• Study countries:
  Italy
• Study description:
  This is a drug utilization study of biological drugs for psoriasis, in the Tuscany region of Italy, from 2011 to 2016.
• Study status:
  Ongoing

Research institutions and networks

Institutions

University of Pisa

Study timelines

Date when funding contract was signed

Planned:06/07/2020

Actual:06/07/2020

Study start date

Planned:01/05/2020

Actual:01/05/2020

Data analysis start date

Planned:01/06/2020

Actual:01/06/2020

Date of final study report

Planned:01/03/2022

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

University

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable